Aramark Multi-Symptom Cold Relief
- Manufacturer
- Western First Aid Safety DBA Aramark | ULTRA SEAL CORPORATION
- Effective date
- 2021-06-03
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 23:40:44
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Drug Facts
Cold Relief Tablets
Active Ingredients (in each tablet)
Acetaminophen 325 mg
Guaifenesein 200 mg
Phenylephrine HCl 5 mg
Dextromethorphan HBr 15 mg
OTC - PURPOSE SECTION
Purpose
Acetaminophen.....................Pain Reliever/Fever Reducer
Guaifenesein ........................Expectorant
Phenylephrine HCl ...............Decongestant
Dextromethorphan HBr. .......Antitussive
INDICATIONS & USAGE SECTION
Uses: temporarily:
• relieves nasal congestion associated with sinusitis
• relieves nasal confestion due to the common cold, hay
fever or other respiratory allergies
• relieves sinus congestion and pressure, helps
decongest sinus openings and passages
• restores free breathing
• helps loosen phlegm (mucus) and thin bronchial
secretions to rid the bronchial passages of
bothersome mucus, drain bronchial tubes, and make
coughs more productive
• temporarily suppresses cough due to minor throat
and bronchial irritation associated with a cold or
inhaled irritants
Temporarily relieves minor aches, pains and fever
associated with: • headache • backache • common
cold • muscular aches • toothache • menstrual cramps
o make coughs more productive
WARNINGS SECTION
Warnings:
Liver Warning: This product containsacetaminophen.
Severe liver damage may occur if you take:
• more than 8 tablets in 24 hours
• with other drugs containing acetaminophen
(prescription or nonprescription)
• Ask a doctor or pharmacist before using with other
drugs if you are not sure
• 3 or more alcoholic drinks every day while using
this product.
OTC - DO NOT USE SECTION
Do not:
• use with any other product containing
acetaminophen. This will provide more than the
recommended dose (overdose) of acetaminophen
and could cause serious health concerns.
• use more than the recommended dose
• for more than 10 days for pain unless directed by
a doctor
• for more than 3 days for fever unless directed by a
doctor
• when using this product do not exceed
recommended dose if you are now taking a
prescription monoamine oxidase inhibitor (MAOI)
(certain drugs for depression, psychiatric or
emotional conditions, or Parkinson’s disease), or for
2 weeks after stopping MAOI drug. If you do not
know if your prescription drug contains an MAOI,
consult a doctor or pharmacist before taking this
product
OTC - STOP USE SECTION
Stop use and ask a doctor if:
• symptoms do not improve
• pain or fever persists or gets worse
• new symptoms occur
• redness or swelling is present
• nervousness, dizziness or sleeplessness occur
• symptoms do not improve within 7 days or are
accompanied by a fever
• cough persists for more than 1 week, tends
to recur, or is
• accompanied by a fever, rash, or persistant headache.
• A persistant cough may be a sign of a serious
condition
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have:
• heart disease
• high blood pressure
• thyroid disease
• diabetes
• difficulty in urination due to enlargement of the
prostate gland
• persistent or chronic cough such as occurs with
smoking,
• asthma, chronic bronchitis, or emphysema or where
cough is
• accompanied by excessive phlegm (mucus)
PREGNANCY SECTION
If pregnant or breast-feedin baby, ask a health
professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of accidental overdose, get
medical help or contact a Poison Control Center right
away. Prompt medical attention is critical for adults as
well as for children even if you do not notice any signs
or symptoms.
DOSAGE & ADMINISTRATION SECTION
| Directions: | |
| • Adults and children 12 years of age and older: | Take 2 tablets every 6 to 8 hours as needed. Do not exceed 8 tablets in 24 hours, or as directed by a doctor. |
| • Children under 12 years: | Consult a doctor. |
OTHER SAFETY INFORMATION
Other Information:
Tamper evident. Do not use if packet is torn, cut or
opened Store at controlled room temperature 15° to
30°C (59° to 86° F) Avoid excessive heat and humidity
INACTIVE INGREDIENT SECTION
Inactive Ingredients:
Maltodextrin, Microcrystalline Cellulose, Povidone,
Sodium Starch Glycolate, Starch, Stearic Acid
Product Labeling
aramark
100 TABLETS
PER BOX Part # 82233B
Multi-Symptom
COLD RELIEF
Non-Pseudo Tablet
Decongestant
Temporary relief of minor
aches, pains, headache,
muscular aches, fever and
nasal congestion associated
with the common cold.
Compare active ingredient to:
DRISTAN Cold and Sinus®
Registered Trademark of Pfizer
Retain carton for complete product information
MANUFACTURED FOR:
Aramark
Lenexa, KS 66219
866-362-2691
aramarkuniform.com
100 Tablet Box
250 Tablet Box
2-Tablet Packet
res
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1367204 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | 1 |
| 1367204 | acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | 1 |
| 1367204 | APAP 325 MG / dextromethorphan hydrobromide 15 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | 1 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81238-0107-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3af4-0266-e053-dadaa90a7c1a | Aramark Multi-Symptom Cold Relief |
| 81238-0107-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3af4-0266-e053-dadaa90a7c1a | Aramark Multi-Symptom Cold Relief |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81238-0107-1 | Aramark Multi-Symptom Cold Relief | 2 in 1 PACKET | TABLET | 2 | 1 | |
| 81238-0107-1 | Aramark Multi-Symptom Cold Relief | 50 in 1 BOX | TABLET | 50 | 1 | |
| 81238-0107-2 | Aramark Multi-Symptom Cold Relief | 2 in 1 PACKET | TABLET | 2 | 1 | |
| 81238-0107-2 | Aramark Multi-Symptom Cold Relief | 125 in 1 BOX | TABLET | 125 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81238-0107 | ARAMARK MULTI-SYMPTOM COLD RELIEF (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR) TABLET [WESTERN FIRST AID SAFETY DBA ARAMARK] | 1 | Legacy NDC, 4 package rows | 20210605_88aee6e7-16d1-413b-af8c-32aee050c724.zip |
Products#
Every source-derived product name is available through these pages.
- Aramark Multi-Symptom Cold Relief
- ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCl, DEXTROMETHORPHAN HBr
- ACETAMINOPHEN
- GUAIFENESIN
- PHENYLEPHRINE HYDROCHLORIDE
- PHENYLEPHRINE
- DEXTROMETHORPHAN HYDROBROMIDE
- DEXTROMETHORPHAN
- MALTODEXTRIN
- CELLULOSE, MICROCRYSTALLINE
- POVIDONE
- SODIUM STARCH GLYCOLATE TYPE A CORN
- STARCH, CORN
- STEARIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 81238-0107 | 81238-0107-1, 81238-0107-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| GUAIFENESIN | 495W7451VQ | ACTIB |
| PHENYLEPHRINE HYDROCHLORIDE | 04JA59TNSJ | ACTIM |
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POVIDONE | FZ989GH94E | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 86f89604-3018-413b-b417-eb58b9d35f95 | 88aee6e7-16d1-413b-af8c-32aee050c724 | 2021-06-03 | Warnings | 86f89604-3018-413b-b417-eb58b9d35f95 88aee6e7-16d1-413b-af8c-32aee050c724 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


